Zobrazeno 1 - 5
of 5
pro vyhledávání: '"E. Roy Berger"'
Autor:
Philip W, Kantoff, Celestia S, Higano, Neal D, Shore, E Roy, Berger, Eric J, Small, David F, Penson, Charles H, Redfern, Anna C, Ferrari, Robert, Dreicer, Robert B, Sims, Yi, Xu, Mark W, Frohlich, Paul F, Schellhammer, J, Young
Publikováno v:
New England Journal of Medicine. 363:411-422
Background Sipuleucel-T, an autologous active cellular immunotherapy, has shown evidence of efficacy in reducing the risk of death among men with metastatic castration-resistant prostate cancer. Methods In this double-blind, placebo-controlled, multi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d41701835f2db94568cec4ddc70b10a
https://doi.org/10.1056/nejmoa1001294
https://doi.org/10.1056/nejmoa1001294
Autor:
E. Roy Berger
Publikováno v:
Community Oncology. 4:447-452
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::511d3292a6f2e50fbf100925c88993db
https://doi.org/10.1016/s1548-5315(11)70104-8
https://doi.org/10.1016/s1548-5315(11)70104-8
Autor:
E. David Crawford, Nelson N. Stone, Evan Y. Yu, Phillip J. Koo, Stephen J. Freedland, Susan F. Slovin, Leonard G. Gomella, E. Roy Berger, Thomas E. Keane, Paul Sieber, Neal D. Shore, Daniel P. Petrylak, Raoul S. Concepcion, Stephen Freedland, Jorge A. Garcia, Larry Karsh, Neal Shore
Publikováno v:
Urology. 83(3)
Prostate cancer is often associated with metastases to bone and/or soft tissue. The progression to metastatic castrate-resistant prostate cancer is a seminal event in disease progression affecting treatment decisions. A multidisciplinary group was co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a5285d8803362928c2787625978f00c8
https://pubmed.ncbi.nlm.nih.gov/24411213
https://pubmed.ncbi.nlm.nih.gov/24411213
Autor:
Nelson N. Stone, Frank E Staggers, E. Roy Berger, E. David Crawford, David G. McLeod, Joseph E. Oesterling, Edward P. DeAntoni, Colleen A. Ross
Publikováno v:
Urology. 48:234-239
To analyze the relationship of age and race to prostate-specific antigen (PSA) levels among participants in a community-based study.A total of 77,700 records of men aged 40 to 79 years were analyzed from a longitudinal study of PSA conducted during P
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f025438fef9965138ad471a00336c47d
https://doi.org/10.1016/s0090-4295(96)00091-x
https://doi.org/10.1016/s0090-4295(96)00091-x
Autor:
Neal D. Shore, E. Roy Berger
Publikováno v:
Oncology Times. 27:4
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::64a1617caacc809a657cbf08b4ce768e
https://doi.org/10.1097/01.cot.0000289676.92698.c8
https://doi.org/10.1097/01.cot.0000289676.92698.c8